However, further investigation is needed to fully harness MAA and anti-MAA antibody as biomarkers for clinical applications and to fully understand the role of MAA and anti-MAA immune responses in the development and/or progression of RA. The gene discussed is NAA10; the disease is rheumatoid arthritis.